| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.1 | 0.002 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | -0.13 | 0.002 |
| mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | -0.097 | 0.002 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | -0.17 | 0.003 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.095 | 0.003 |